Published in Tissue Antigens on May 01, 1997
Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. Ann Rheum Dis (1998) 2.17
Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement. Ann Rheum Dis (1999) 1.99
What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using x rays and magnetic resonance imaging over the first two years of disease. Ann Rheum Dis (2001) 1.30
Possession of human leucocyte antigen DQ6 alleles and the rate of CD4 T-cell decline in human immunodeficiency virus-1 infection. Immunology (2004) 0.92
Hypervariable-control-region sequences reveal global population structuring in a long-distance migrant shorebird, the Dunlin (Calidris alpina). Proc Natl Acad Sci U S A (1993) 1.66
HLA-DQ1 associated with reflex sympathetic dystrophy. Neurology (1999) 1.50
T-cell receptor V beta-family usage in primary cutaneous and primary nodal T-cell non-Hodgkin's lymphomas. J Invest Dermatol (1992) 1.43
High-resolution HLA-DPB typing based upon computerized analysis of data obtained by fluorescent sequencing of the amplified polymorphic exon 2. Hum Immunol (1993) 1.29
Common and well-documented HLA alleles: 2012 update to the CWD catalogue. Tissue Antigens (2013) 1.22
The absence of DR51 in a DRB5-positive individual DR2ES is caused by a null allele (DRB5*0108N) Tissue Antigens (1997) 1.04
A multicenter international evaluation of single-tube amplification protocols for sequencing-based typing of HLA-DRB1 and HLA-DRB3,4,5. Tissue Antigens (2004) 1.02
Histocompatibility antigens and other genetic markers in ankylosing spondylitis and inflammatory bowel diseases. J Immunogenet (1977) 1.01
Detection of cytomegalovirus (CMV) in granulocytes by polymerase chain reaction compared with the CMV antigen test. J Clin Microbiol (1992) 1.01
Maternal-specific methylation of the human IGF2R gene is not accompanied by allele-specific transcription. Genomics (1996) 0.99
HLA-DRw4 in Felty's syndrome. Arthritis Rheum (1980) 0.97
HLA-DO polymorphism associated with resistance to type I diabetes detected with monoclonal antibodies, isoelectric point differences, and restriction fragment length polymorphism. J Exp Med (1986) 0.96
Identification of human ccn2 (connective tissue growth factor) promoter polymorphisms. Mol Pathol (2001) 0.95
Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants. Tissue Antigens (2009) 0.95
Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients. Am J Pathol (1996) 0.95
Mitochondrial control-region sequences in two shorebird species, the turnstone and the dunlin, and their utility in population genetic studies. Mol Biol Evol (1994) 0.94
HLA-DP antibodies before and after renal transplantation. Tissue Antigens (2010) 0.91
Going back to the roots: effective utilisation of HLA typing information for bone marrow registries requires full knowledge of the DNA sequences of the oligonucleotide reagents used in the testing. Tissue Antigens (2000) 0.91
Reanalysis of sequence-based HLA-A, -B and -Cw typings: how ambiguous is today's SBT typing tomorrow. Tissue Antigens (2007) 0.90
Genetic variability and linkage disequilibrium within the DP region in the CEPH families. Hum Immunol (1997) 0.89
Localization of HLA on the short arm of chromosome 6. Hum Genet (1977) 0.89
HLA class II amino acid epitopes as susceptibility markers of sarcoidosis. Tissue Antigens (2007) 0.89
The origins of multiple squamous cell carcinomas in the aerodigestive tract. Cancer (2000) 0.87
Dissection of HLA class II haplotypes in HLA-DR4 homozygous individuals. Immunogenetics (1986) 0.87
High-resolution HLA typing for the DQB1 gene by sequence-based typing. Tissue Antigens (1998) 0.87
Automated, solid-phase sequencing of DRB region genes using T7 sequencing chemistry and dye-labeled primers. Tissue Antigens (1995) 0.86
Sequencing-based typing reveals new insight in HLA-DPA1 polymorphism. Tissue Antigens (1995) 0.86
T cell receptor V beta variable gene family expression in human peripheral blood lymphocytes at the mRNA and membrane protein level. Clin Exp Immunol (1992) 0.86
Aberrant oestrogen receptor species in human meningioma tissue. J Steroid Biochem Mol Biol (1992) 0.86
Sequencing-based typing reveals six novel MHC class I chain-related gene B (MICB) alleles. Tissue Antigens (1998) 0.85
Increased incidence of HLA-DR2 in patients with pernicious anemia. Tissue Antigens (1982) 0.85
Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers. Lab Invest (1999) 0.84
Luminex donor-specific crossmatches. Tissue Antigens (2008) 0.84
Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression. J Oral Pathol Med (1998) 0.84
B*27 in molecular diagnostics: impact of new alleles and polymorphism outside exons 2 and 3. Tissue Antigens (2002) 0.84
Correlations between polymorphisms at the DNA and at the protein level of DRw52 haplotypes, revealed with a variety of techniques. Hum Immunol (1988) 0.83
Role of human leucocyte antigen DQ in the presentation of T cell epitopes in the major cow's milk allergen alphas1-casein. Int Arch Allergy Immunol (2007) 0.83
High level of chromosome 15 aneuploidy in head and neck squamous cell carcinoma lesions identified by FISH analysis: limited value of beta2-microglobulin LOH analysis. Tissue Antigens (2004) 0.82
Identification of two new nucleotide mutations (HPRTUtrecht and HPRTMadrid) in exon 3 of the human hypoxanthine-guanine phosphoribosyltransferase (HPRT) gene. Hum Genet (1993) 0.82
A computerized method to predict the discriminatory properties for class II sequencing based typing. Hum Immunol (1996) 0.81
Sensitive detection of p53 mutation: analysis by direct sequencing and multisequence analysis. Cancer Detect Prev (2001) 0.81
Detection of HLA class I and II antibodies by ELISA and complement-dependent cytotoxicity before and after transplantation. Transplantation (2000) 0.81
Assignment of HLA-DPB alleles by computerized matching based upon sequence data. Hum Immunol (1993) 0.81
Asian Indian HLA-DR2-, DR4-, and DR52-related DR-DQ genotypes analyzed by polymerase chain reaction based nonradioactive oligonucleotide typing. Unique haplotypes and a novel DR4 subtype. Hum Immunol (1994) 0.81
No association between IL-10 promoter gene polymorphism and heart failure or rejection following cardiac transplantation. Tissue Antigens (2001) 0.81
Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells. Bone Marrow Transplant (1998) 0.81
Six newly identified HLA-DRB alleles: DRB1*1121, *1419, *1420, *1421, DRB3*0203 and DRB5*0103. Tissue Antigens (1996) 0.80
Serology versus PCR-SSP in typing for HLA-DR and HLA-DQ: a practical evaluation. Tissue Antigens (1995) 0.80
Characterization and distribution of Mhc-DPB1 alleles in chimpanzee and rhesus macaque populations. Hum Immunol (1998) 0.80
Updated characterization of ancestral haplotypes using the Fourth Asia-Oceania Histocompatibility Workshop panel. Hum Immunol (1995) 0.80
Molecular localization of LB-Q1, a DRw52-like T-cell recognition epitope and identification at the genomic level of associated shared hybridizing fragments. Hum Immunol (1987) 0.80
Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia. J Med Genet (1997) 0.79
Complete donor T cell chimerism is accomplished in patients transplanted with bone marrow grafts containing a fixed low number of T cells. Bone Marrow Transplant (1996) 0.79
Transforming growth factor-alpha and epidermal growth factor expression in the exocrine pancreas of azaserine-treated rats: modulation by cholecystokinin or a low fat, high fiber (caloric restricted) diet. Carcinogenesis (1995) 0.79
Sequence-based typing of HLA-DQA1: comprehensive approach showed molecular heterogeneity. Tissue Antigens (2007) 0.79
IgE production after antigen-specific and cognate activation of HLA-DPw4-restricted T-cell clones, by 78% of randomly selected B-cell donors. Hum Immunol (2000) 0.79
Human leukocyte antigen sensitization after cryopreserved human meniscal transplantations. Transplantation (1997) 0.79
HLA-DR1 and rheumatoid arthritis in Israeli Jews: sequencing reveals that DRB1*0102 is the predominant HLA-DR1 subtype. Tissue Antigens (1993) 0.79
Polymorphisms within the HLA-DRw6 haplotype. III. DQ alpha and DQ beta polymorphism associated with HLA-D. Hum Immunol (1987) 0.79
Donor-specific antibodies after transplantation by flow cytometry: relative change in fluorescence ratio most sensitive risk factor for graft survival. Transplantation (1998) 0.79
Sequenase sequence profiles used for HLA-DPB1 sequencing-based typing. Tissue Antigens (1996) 0.79
Criteria to define HLA haplotype loss in human solid tumors. Tissue Antigens (2000) 0.78
An overview of the restriction fragment length polymorphism of the HLA-D region: its application to individual D-, DR- typing by computerized analyses. Tissue Antigens (1986) 0.78
HLA-DPB1*0401 is associated with dominant protection against type 1 diabetes in the general Saudi population and in subjects with a high-risk DR/DQ haplotype. Eur J Immunogenet (2003) 0.78
A reliable and efficient high resolution typing method for HLA-C using sequence-based typing. Tissue Antigens (1998) 0.78
Allelic polymorphism in introns 1 and 2 of the HLA-DQA1 gene. Tissue Antigens (2005) 0.78
Mapping of susceptibility to Marek's disease within the major histocompatibility (B) complex by refined typing of White Leghorn chickens. Anim Genet (1993) 0.78
Expression of T-cell receptor alpha and beta variable genes in normal and malignant human T cells. Br J Haematol (1993) 0.78
Cytokine messenger RNA expression by donor-specific cytotoxic T-cell clones after allogeneic heart transplantation. J Heart Lung Transplant (1997) 0.78
HLA class II DNA analysis by RFLP reveals novel class II polymorphism. Hum Immunol (1987) 0.78
Intron sequences of HLA-B*73. Tissue Antigens (2001) 0.78
Strong association between HLA-Cw*0706 and HLA-B*44032 in the Bubi population from Equatorial Guinea. Tissue Antigens (2000) 0.78
A generic sequencing based typing approach for the identification of HLA-A diversity. Hum Immunol (1997) 0.78
Monitoring of residual disease and guided donor leucocyte infusion after allogeneic bone marrow transplantation by chimaerism analysis with short tandem repeats. Br J Haematol (2000) 0.77
Expression of two interleukin 4 mRNA isoforms in B lymphoid cells. Cell Immunol (1996) 0.77
Unexpected Bw4 and Bw6 reactivity patterns in new alleles. Tissue Antigens (2000) 0.77
Polymorphism and complexity of HLA-DR: evidence for intra-HLA-DR region crossing-over events. Immunogenetics (1988) 0.77
Segregation of HLA haplotypes in 100 families with a myasthenia gravis patient. J Immunogenet (1977) 0.77
Microsatellite analysis of microdissected tumor cells and 6p high density microsatellite analysis in head and neck squamous cell carcinomas with down-regulated human leukocyte antigen class I expression. Lab Invest (2000) 0.77
HLA-A towards a high-resolution DNA typing. Tissue Antigens (1998) 0.77
Ambiguous DPB1 allele combinations resolved by direct sequencing of selectively amplified alleles. Tissue Antigens (1995) 0.76
p53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 mutations in primary tumor and matched lymph node metastases. Oral Oncol (1999) 0.76
No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients. Transplantation (1996) 0.76
The effect of serologically defined major histocompatibility complex haplotypes on Marek's disease resistance in commercially bred White Leghorn chickens. Avian Dis (1991) 0.76
Polymorphism of intron 4 in HLA-A, -B and -C genes. Tissue Antigens (2003) 0.76
HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome. Transplantation (1999) 0.76
A novel HLA-A24 (A*2420) allele identified in the Atayal tribe of Taiwan. Tissue Antigens (2000) 0.75
Human oesophageal adenocarcinoma cell lines JROECL 47 and JROECL 50 are admixtures of the human colon carcinoma cell line HCT 116. Br J Cancer (2000) 0.75
A high recombination frequency within the chicken major histocompatibility (B) complex. Anim Genet (1993) 0.75
Polymorphisms within the HLA-DRw6 haplotype. I. Restriction fragment length variation and its correlation with serology. J Immunol (1985) 0.75